12/27/18 18:00 | 12/24/18 | PRVB | Provention Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Catlin Avery W | NJ | D | | P.m | 19 | 1.88 | 0 | 10 | 100 | 20 | I | | | | | | | | | | | | | | |
11/13/18 07:00 | 11/9/18 | PRVB | Provention Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Catlin Avery W | NJ | D | | P | 32 | 3.15 | 0 | 10 | New | 10 | I | | | | | | | | | | | | | | |
5/12/17 10:46 | 5/11/17 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Catlin Avery W | MA | D | | P | 31 | 6.15 | 5 | 5 | 12 | 47 | D | 54 | 153 | 8 | -2 | -23 | -5 | -11 | -1 | 2 | | | | | |
11/22/16 14:40 | 11/22/16 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Catlin Avery W | MA | D | | P | 15 | 7.55 | 15 | 2 | 5 | 42 | D | 138 | 362 | 209 | 102 | -19 | 49 | 30 | 1 | 1 | 2 | 8 | 5 | | |
9/7/16 12:59 | 9/2/16 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Catlin Avery W | NJ | O | SVP,CFO | M.d | 28 | 2.80 | 10 | 10 | 14 | 84 | D | -77 | -75 | -4 | -24 | -24 | -20 | 2 | 6 | 4 | 1 | 24 | 7 | -1 | |
6/6/16 08:26 | 6/3/16 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Catlin Avery W | NJ | O | SVP,CFO | M.d | 69 | 3.01 | 12 | 23 | 45 | 74 | D | -66 | -83 | -74 | -44 | 12 | 22 | 8 | 0 | 6 | -10 | -1 | -26 | -22 | |
3/10/16 07:59 | 3/9/16 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Catlin Avery W | NJ | O | SVP,CFO | M.d | 42 | 2.80 | 30 | 15 | 42 | 51 | D | -85 | -87 | -75 | -76 | -62 | -48 | -47 | -56 | 0 | -11 | 29 | 30 | 1 | -5 |
11/25/15 16:09 | 11/23/15 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Catlin Avery W | NJ | O | SVP,CFO | M.d | 213 | 8.52 | 33 | 25 | 247 | 35 | D | -37 | -15 | -39 | 24 | 32 | 36 | 25 | 23 | 0 | -1 | -8 | -58 | -77 | -76 |
11/25/15 16:09 | 11/23/15 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Catlin Avery W | NJ | O | SVP,CFO | S.d | -450 | 18.00 | 33 | -25 | -42 | 35 | D | -37 | -15 | -39 | 24 | 32 | 36 | 25 | 23 | 0 | -1 | -8 | -58 | -77 | -76 |
9/14/15 08:21 | 9/11/15 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Catlin Avery W | NJ | O | SVP,CFO | M.d | 45 | 4.50 | 27 | 10 | 40 | 35 | D | -34 | 0 | -48 | -39 | -34 | 14 | 8 | 5 | 0 | 0 | -17 | -1 | -77 | -76 |
8/19/15 08:14 | 8/18/15 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Catlin Avery W | MA | D | | P | 16 | 1.90 | 0 | 8 | 26 | 40 | D | | | -11 | -54 | -39 | -6 | -1 | 2 | 40 | 3 | 12 | -9 | -36 | 76 |
8/18/15 09:12 | 8/17/15 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Catlin Avery W | MA | D | | P | 23 | 1.94 | 0 | 12 | 59 | 32 | D | | | -12 | -54 | -37 | -1 | -4 | -3 | -3 | 0 | 8 | -11 | -33 | 58 |
6/16/15 16:19 | 6/15/15 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Catlin Avery W | NJ | O | SVP,CFO | M.d | 213 | 8.52 | 33 | 25 | | 25 | D | 54 | 44 | 36 | -20 | -2 | -11 | -6 | -3 | -1 | 9 | 9 | -37 | -41 | -82 |
6/16/15 16:19 | 6/15/15 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Catlin Avery W | NJ | O | SVP,CFO | S.d | -615 | 24.59 | 33 | -25 | -50 | 25 | D | 54 | 44 | 36 | -20 | -2 | -11 | -6 | -3 | -1 | 9 | 9 | -37 | -41 | -82 |
6/9/15 16:18 | 6/9/15 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Catlin Avery W | MA | D | | P | 62 | 3.10 | 0 | 20 | New | 20 | D | | | -4 | -2 | 0 | -27 | -8 | 1 | 0 | 11 | 0 | -39 | -44 | 6 |
9/9/14 13:53 | 9/8/14 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Catlin Avery W | NJ | O | SVP,CFO | M.d | 45 | 4.50 | 30 | 10 | 68 | 25 | D | 168 | -35 | -38 | -5 | 18 | 1 | -4 | -2 | -3 | -8 | -15 | 18 | 83 | -5 |
12/10/13 16:15 | 12/6/13 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Catlin Avery W | MA | O | SVP,CFO | M.d | 1,496 | 8.16 | 33 | 183 | | 14 | D | 751 | 342 | 57 | -1 | 4 | 1 | -11 | -7 | -7 | 0 | -3 | 3 | -26 | -22 |
12/10/13 16:15 | 12/6/13 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Catlin Avery W | MA | O | SVP,CFO | S.d | -4,492 | 24.50 | 33 | -183 | -93 | 14 | D | 751 | 342 | 57 | -1 | 4 | 1 | -11 | -7 | -7 | 0 | -3 | 3 | -26 | -22 |
8/10/11 09:52 | 8/9/11 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Catlin Avery W | MA | O | SVP,CFO | P | 5 | 2.39 | 1 | 2 | New | 2 | D | -60 | -47 | -25 | -32 | -27 | -23 | -26 | -11 | -8 | 7 | 6 | 9 | 95 | 76 |
9/9/10 11:57 | 9/8/10 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Catlin Avery W | MA | O | SVP,CFO | P | 7 | 3.51 | 3 | 2 | New | 2 | D | -69 | -34 | -34 | -26 | -30 | -25 | -20 | -26 | -4 | 7 | 22 | 17 | 12 | -13 |
12/1/09 09:55 | 11/30/09 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Catlin Avery W | MA | O | SVP,CFO | P | 4 | 4.41 | 1 | 1 | New | 1 | D | -22 | -30 | -56 | -21 | -11 | -13 | -12 | -4 | 0 | 2 | 3 | 23 | 45 | -8 |
8/16/06 16:28 | 8/16/06 | AVAN | Avant Immunotherapeutics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Catlin Avery W | MA | O | SVP,CFO | P | 7 | 1.35 | 0 | 5 | 31 | 21 | D | | | | | | | | | | | | | | |
11/22/05 12:06 | 11/22/05 | AVAN | Avant Immunotherapeutics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Catlin Avery W | MA | O | SVP,CFO | M.d | 6 | 1.14 | 0 | 5 | 48 | 16 | D | | | | | | | | | | | | | | |
8/4/04 11:51 | 8/3/04 | AVAN | Avant Immunotherapeutics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Catlin Avery W | MA | O | SVP,CFO | P | 6 | 1.83 | 0 | 4 | 54 | 10 | D | | | | | | | | | | | | | | |